Abstract
Background Digital pathology significantly improves diagnostic efficiency and accuracy; however, pathological tissue sections are scanned at high resolutions (HR), magnified by 40 times (40X) incurring high data volume, leading to storage bottlenecks for processing large numbers of whole slide images (WSIs) for later diagnosis in clinic and hospitals.
Method We propose to scan at a magnification of 5 times (5X). We developed a novel multi-scale deep learning super-resolution (SR) model that can be used to accurately computes 40X SR WSIs from the 5X WSIs.
Results The required storage size for the resultant data volume of 5X WSIs is only one sixty-fourth (less than 2%) of that of 40X WSIs. For comparison, three pathologists used 40X scanned HR and 40X computed SR WSIs from the same 480 histology glass slides spanning 47 diseases (such tumors, inflammation, hyperplasia, abscess, tumor-like lesions) across 12 organ systems. The results are nearly perfectly consistent with each other, with Kappa values (HR and SR WSIs) of 0.988±0.018, 0.924±0.059, and 0.966±0.037, respectively, for the three pathologists. There were no significant differences in diagnoses of three pathologists between the HR and corresponding SR WSIs, with Area under the Curve (AUC): 0.920±0.164 vs. 0.921±0.158 (p-value=0.653), 0.931±0.128 vs. 0.943±0.121 (p-value=0.736), and 0.946±0.088 vs. 0.941±0.098 (p-value=0.198). A previously developed highly accurate colorectal cancer artificial intelligence system (AI) diagnosed 1,821 HR and 1,821 SR WSIs, with AUC values of 0.984±0.016 vs. 0.984±0.013 (p-value=0.810), again with nearly perfect matching results.
Conclusions The pixel numbers of 5X WSIs is only less than 2% of that of 40X WSIs. The 40X computed SR WSIs can achieve accurate diagnosis comparable to 40X scanned HR WSIs, both by pathologists and AI. This study provides a promising solution to overcome a common storage bottleneck in digital pathology.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by National Natural Science Foundation of China (81972490) the Natural Science Foundation of Hunan Province (2023JJ30737) and the Tongxing Pathology Public Welfare Project from Peking Union Medical College Foundation and the Social Development Project of Science and Technology Department of Shaanxi Province (2023-YBSF-465) and the Science and Technology Plan Project of Xian Science and Technology Bureau (22YXYJ0108).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The IRB of School of Basic Medical Science, Central South University gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
